Johnson & Johnson forecasts $2.5B of coronavirus vaccine sales

Johnson & Johnson forecasts $2.5B of coronavirus vaccine sales



Johnson & Johnson said it will sell $2.5 billion worth of its COVID-19 vaccine this year and pushed back against concerns over its effectiveness against the delta variant.